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Abstract
Objective To assess the effectiveness of physiotherapy compared with
no intervention in patients with Parkinson’s disease.
Design Systematic review and meta-analysis of randomised controlled
trials.
Data sources Literature databases, trial registries, journals, abstract
books, and conference proceedings, and reference lists, searched up
to the end of January 2012.
ReviewmethodsRandomised controlled trials comparing physiotherapy
with no intervention in patients with Parkinson’s disease were eligible.
Two authors independently abstracted data from each trial. Standard
meta-analysis methods were used to assess the effectiveness of
physiotherapy compared with no intervention. Tests for heterogeneity
were used to assess for differences in treatment effect across different
physiotherapy interventions used. Outcome measures were gait,
functional mobility and balance, falls, clinician rated impairment and
disability measures, patient rated quality of life, adverse events,
compliance, and economic analysis outcomes.
Results 39 trials of 1827 participants met the inclusion criteria, of which
29 trials provided data for the meta-analyses. Significant benefit from
physiotherapy was reported for nine of 18 outcomes assessed. Outcomes
which may be clinically significant were speed (0.04 m/s, 95% confidence
interval 0.02 to 0.06, P<0.001), Berg balance scale (3.71 points, 2.30
to 5.11, P<0.001), and scores on the unified Parkinson’s disease rating
scale (total score −6.15 points, −8.57 to −3.73, P<0.001; activities of
daily living subscore −1.36, −2.41 to −0.30, P=0.01; motor subscore
−5.01, −6.30 to −3.72, P<0.001). Indirect comparisons of the different
physiotherapy interventions found no evidence that the treatment effect
differed across the interventions for any outcomes assessed, apart from
motor subscores on the unified Parkinson’s disease rating scale (in
which one trial was found to be the cause of the heterogeneity).
Conclusions Physiotherapy has short term benefits in Parkinson’s
disease. A wide range of physiotherapy techniques are currently used
to treat Parkinson’s disease, with little difference in treatment effects.
Large, well designed, randomised controlled trials with improved
methodology and reporting are needed to assess the efficacy and cost
effectiveness of physiotherapy for treating Parkinson’s disease in the
longer term.
Introduction
Parkinson’s disease is a complex neurodegenerative disorder1
with wide reaching implications for patients and their families.
Themanagement of Parkinson’s disease has traditionally centred
on drug treatment,2 but even with optimal medical management,
patients still experience a deterioration of body function, daily
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activities, participation,3 and decline in mobility.4 This can lead
to increased dependence on others, inactivity,5 and social
isolation,4 resulting in reduced quality of life.4 There has been
increasing support for the inclusion of rehabilitation therapies
as an adjuvant to pharmacological and neurosurgical treatment,6 3
and a call for the move towards multidisciplinary
management.1 7 8 The physiotherapist is a member within this
multidisciplinary team,1 9 with the purpose of maximising
functional ability and minimising secondary complications
through movement rehabilitation within a context of education
and support for the whole person.10 11 Physiotherapy for
Parkinson’s disease focuses on transfers, posture, upper limb
function, balance (and falls), gait, and physical capacity and
(in)activity. It also uses cueing strategies, cognitive movement
strategies, and exercise to maintain or increase independence,
safety, and quality of life.4 12
Referral rates to physiotherapy for people with Parkinson’s
disease have historically been low, owing to a weak evidence
base and poor availability of physiotherapy services.13 14 In recent
years, supportive evidence for the inclusion of physiotherapy
in the management of Parkinson’s disease has grown, due to
the increased number of trials particularly in the past five years.15
Recent management guidelines have supported physiotherapy,
such as those from the United Kingdom National Institute for
Health and Clinical Excellence (NICE)16 and the Royal Dutch
Society of Physical Therapy.17 This has led to an increased
number of referrals, with a survey by Parkinson’s UK in 2008
reporting that 54% of the 13 000 members surveyed had seen
a physiotherapist.18
To synthesise the latest trial reports with the older data, we have
performed this systematic review and meta-analysis of all
randomised controlled trials of physiotherapy in Parkinson’s
disease. This review includes trials assessing a variety of
different physiotherapy methods as used to treat people with
Parkinson’s disease, to provide an overall assessment on the
use of physiotherapy in this patient population. Previous reviews
have focused on one type of physiotherapy (such as exercise or
treadmill training).19 20 Detailed results have been published in
the Cochrane Library21 updating the Cochrane review published
in 2001.11
Methods
Search strategy and selection criteria
A systematic search of the literature to the end of January 2012
was undertaken using a highly sensitive search strategy as
recommended by the Cochrane Collaboration.22 We combined
text and, where appropriate, Medical Subject Heading terms for
physiotherapy, physical therapy, exercise, or rehabilitation; and
Parkinson, Parkinson’s disease, or parkinsonism. No language
restrictions were applied. We identified relevant trials by
electronic searches of general biomedical and science electronic
databases (Medline, Embase, Cumulative Index to Nursing and
Allied Health Literature, Web of Science), rehabilitation
databases (Allied and Complimentary Medicine Database,
REHABDATA, REHADAT, GEROLIT); English language
databases of foreign language research and third world
publications (Latin American and Caribbean Health Sciences
Literature, MedCarib, Index medicus for the Eastern
Mediterranean region); conference and grey literature databases
(Conference Proceedings Citation Index, Dissertation Abstracts,
Conference Papers Index, Index to Theses, Electronic Theses
Online Service, ProQuest), and trial registries (Cochrane Central
Register of Controlled Trials, CentreWatch Clinical Trials listing
service, metaRegister of Controlled Trials, ClinicalTrials.gov,
Research Portfolio Online Reporting Tools, Physiotherapy
Evidence Database, National Institute of disability and
rehabilitation register, National research register). We also hand
searched relevant general (for example, Lancet, BMJ, JAMA)
and specific journals (for example, Movement Disorders,
Neurology, Archives of Physical Medicine and Rehabilitation,
Clinical Rehabilitation, Physiotherapy, Physical Therapy),
abstract books, and conference proceedings (International
Congress of Parkinson’s Disease and Movement Disorders,
World Congress on Parkinson’s Disease and RelatedDisorders),
as well as examined the reference lists of identified papers and
other reviews.
Study selection
Studies eligible for this review were randomised controlled
trials (including the first phase of crossover trials) of patients
with Parkinson’s disease comparing a physiotherapy intervention
with no intervention or placebo control. Physiotherapy
encompasses a wide range of techniques, so we were inclusive
in our definition of physiotherapy intervention, including trials
of general physiotherapy, exercise, treadmill training, cueing,
dance, and martial arts versus no intervention.
General physiotherapy was a broad category, including a variety
of techniques traditionally used by physiotherapists to treat
people with Parkinson’s disease. Trials in this category may
includemultifaceted interventions using both active participation
in treatment by the patient (such as exercise and practising of
functional activities) and hands-on techniques delivered by the
therapist (for example, massage, passive stretching, the Bobath
technique). Exercise interventions were those that included only
active exercise participation techniques targeting a variety of
symptoms, such as balance, falls prevention, and walking speed.
An existing Cochrane review analysed trials of treadmill training
for Parkinson’s disease, and thus these trials were considered
separately to other exercise interventions. Martial arts and dance
interventions included participation in universally recognised
activities not specifically designed for treating disease, but which
appeared in trials of Parkinson’s disease evaluating relevant
physiotherapy outcome measures. We excluded trials of
multidisciplinary team interventions because it was difficult to
ascertain the amount of physiotherapy input. Ultimately, all
trials were meta-analysed to give an overall picture of the effect
of delivery of a physiotherapy intervention versus no
physiotherapy intervention.
Data extraction and quality assessment
All articles were read by two independent review authors (CLT,
SP, CM, or CPH) and data extracted according to predefined
criteria, with any discrepancies resolved by discussion.
Publications were assessed for methodological quality by
recording specified eligibility criteria, method of randomisation
and blinding, concealment of allocation, similarity of patients
in treatment groups at baseline, variation in cointerventions
received by patients throughout the trial period, whether an
intention to treat analysis was performed, and the number of
patients lost to follow-up.
Quantitative data synthesis
Outcome data included gait outcomes (such as the two or six
min walk test, 10 or 20 m walk test, speed, cadence, stride and
step length, freezing of gait questionnaire), functional mobility
and balance outcomes (such as the timed up and go test,
functional reach test, Berg balance scale, activities specific
balance confidence scale), falls data (such as number of falls,
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e5004 doi: 10.1136/bmj.e5004 (Published 6 August 2012) Page 2 of 14
RESEARCH
falls efficacy scale), clinician rated disability scales (such as the
unified Parkinson’s disease rating scale (UPDRS)), patient rated
quality of life (such as Parkinson’s disease questionnaire 39),
adverse events, compliance or withdrawals, and health
economics where available.
Results of each trial were combined using standardmeta-analytic
methods to estimate an overall effect for physiotherapy versus
no intervention. Since all outcomes were continuous variables,
weighted mean difference methods were used.23 Briefly, for
each trial, this involved calculating the mean change (and
standard deviation) from baseline to the time point after
intervention, for both the intervention and no intervention
groups. From these numbers, the mean difference and its
variance between arms for each trial could be calculated and
then combined using a fixed effects model.
The primary analysis was a comparison of physiotherapy with
no intervention (control) using change from baseline to the first
assessment after treatment (which, in most cases, was
immediately after intervention). This comparison was chosen
as the primary analysis, because in most trials it was the main
data analysis reported, and few trials reported data at assessment
points in the longer term (that is, after six months). Some trials
also allowed patients in the control group to receive
physiotherapy intervention after this point, so this primary
analysis allowed a clean comparison of physiotherapy
intervention versus no intervention.
Since the different trials implemented various types of
physiotherapy, trials were divided according to the type of
intervention (general physiotherapy, exercise, treadmill, cueing,
dance, or martial arts). If any trials with three or more treatment
arms were identified, wemade two assumptions for the analysis.
Firstly, if the trial was comparing two or more physiotherapy
methods in the same category of intervention (as described
above) versus control, then the data for those physiotherapy
arms were combined to give one comparison of physiotherapy
intervention versus control for that trial.
Secondly, if the trial was comparing two or more physiotherapy
methods that were in different categories (as described above)
versus control, then the data for those physiotherapy arms were
kept separate, and the data for that trial were included in the
appropriate physiotherapy categories. Therefore, in some cases,
the control arms for some trials were included twice in the
analysis. However, this related to only a small number of trials
and patients, and it was judged that this double inclusion would
not overly influence the analysis. We used tests of heterogeneity
to make indirect comparisons to investigate whether the
treatment effect differed across the different intervention
categories.24
Results
Of 76 potentially relevant studies identified, 31 were excluded
(for example, studies were not properly randomised, or crossover
trials did not report data for the first intervention period) and
six were ongoing trials for which no data were available (fig
1⇓). Therefore, we included 39 randomised controlled trials of
1827 patients in the systematic review (fig 1, web table 1).25-63
There were nine trials with multiple arms.27 31 37 38 40 45 52 55 60 In
five trials, two intervention arms were in the same physiotherapy
category; therefore, these arms were combined to give one
physiotherapy comparison versus no intervention.37 40 52 55 60 In
five trials, two intervention arms were in different physiotherapy
categories, so the trial contributed data to two physiotherapy
comparisons.27 31 38 45 60 This meant that these five trials were
included multiple times in the analysis, and the control arms
from these trials were counted more than once. Therefore, 39
trials contributed data for 44 comparisons within the six different
physiotherapy interventions (physiotherapy n=7, exercise n=14,
treadmill training n=8, cueing n=9, dance n=2, and martial arts
n=4, table 1⇓).
Methodological quality
The amount of methodological detail reported in the trials was
variable, with several quality indicators not fully discussed in
many publications (fig 2⇓, web table 2). Only six (15%)
studies26 32 33 36 57 59 reported a sample size calculation in the trial
report. Less than half of the trials described the randomisation
method used, and information on concealment of treatment
allocation was also poorly reported (14 (36%)). Blinded
assessors were used in 24 (62%) studies (although in one study,
the assessors correctly guessed the treatment allocation in nearly
30% of patients33). Finally, only nine trials stated intention to
treat as the primary method of analysis,29 32 33 36 39 40 47 57 63 three
trials stated per protocol as the primary method of analysis,34 52 55
and the remaining trials did not describe the method of analysis.
Data available for analysis
Of 13 trials reported in abstract form, five had data available
for meta-analysis.34 37 39 51 55 From the studies with full
publications, one trial had relevant data that could not be
extracted because it was only available in graph form,56 and
another trial published only median and interquartile range data,
which could not be meta-analysed in this format.30 Therefore,
data were not available from ten trials, and data available for
meta-analysis was provided by 29 trials.
Effects of intervention
Gait outcomes
Speed was significantly increased with physiotherapy compared
with no intervention (mean difference 0.04m/s, 95% confidence
interval 0.02 to 0.06; P<0.001, fig 3⇓). There were also benefits
of borderline significance for the two or six minute walk test
and the freezing of gait questionnaire.We saw a greater increase
in the distance walked in two or six mins (13.37 m, 0.55 to
26.20; P=0.04, web figure 1) and an improvement in score for
the freezing of gait questionnaire (−1.41, −2.63 to −0.19;
P=0.02, web figure 2) after physiotherapy. By contrast, we saw
borderline significance in favour of no intervention for the time
taken to walk 10 or 20 m (0.40 s, 0.00 to 0.80; P=0.05, web
figure 3). There was no significant difference between
physiotherapy and no intervention for cadence (−1.57 steps/min,
−3.81 to 0.67; P=0.17), stride length (0.03 m, −0.02 to 0.08;
P=0.24), and step length (0.02 m, 0.00 to 0.04; P=0.06), (table
2⇓).
Functional mobility and balance outcomes
We found significant improvements with physiotherapy for the
timed up and go test (−0.63 s, 95% confidence interval −1.05
to −0.21; P=0.003), functional reach test (2.16 cm, 0.89 to 3.43;
P<0.001), and Berg balance scale (3.71 points, 2.30 to 5.11;
P<0.001); (table 2, figs 4-6⇓⇓⇓). There was no difference with
physiotherapy compared with no intervention for activity
specific balance confidence scale (2.40 points, −2.78 to 7.57;
P=0.36; table 2).
In the analysis for the timed up and go test, one trial was heavily
weighted in the analysis owing to small standard deviations
compared with other studies (fig 4).60 Furthermore, in the trial
publication, a non-significant effect of martial arts intervention
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was reported (P=0.093), but when the data as reported in the
paper were included in our analysis, a significant difference was
found (P=0.003).We contacted the authors of this study to check
whether the data reported in the paper were in fact standard
errors, but they were confirmed as standard deviations. We
therefore performed a sensitivity analysis, removing this study,
and found that the overall result became not significant (−0.38
s, 95% confidence interval −0.96 to 0.21; P=0.21); thus, this
result should be interpreted with caution.
Falls
Seven trials collected data for falls using a falls diary, reporting
either the number of patients falling or the number of falls per
patient.33 36 39 50 57 61 62 For both outcomes, there was a decrease
in falls after physiotherapy. However, only three studies
compared the two treatment groups, with two reporting no
difference between the arms,50 57 and one reporting a significant
difference favouring physiotherapy intervention.61 We saw no
difference in the falls efficacy scale between the two treatment
arms (−1.91 points, 95% confidence interval −4.76 to 0.94;
P=0.19; table 2).
Clinician rated disability on UPDRS
The UPDRS motor score improved with physiotherapy
compared with no intervention (−5.01 points, 95% confidence
interval −6.30 to −3.72; P<0.001, fig 7⇓). We also saw
significant improvements in the UPDRS subscore for activities
of daily living (−1.36 points, −2.41 to −0.30; P=0.01; web figure
4) and total scores with physiotherapy (−6.15, −8.57 to −3.73;
P<0.001; web figure 5), but no difference in mental subscore
(−0.44, −0.98 to 0.09; P=0.10; table 2).
Patient rated quality of life using Parkinson’s
disease questionnaire 39
Only data for the mobility domain and summary index of the
Parkinson’s disease questionnaire 39 were available for
meta-analysis. We saw no difference between treatment arms
for either overall patient rated quality of life using the summary
index (−0.38 points, 95% confidence interval −2.58 to 1.81;
P=0.73) or the mobility domain (−1.43, −8.03 to 5.18; P=0.67).
Treatment compliance, adverse events, and
health economics
Only 14 trials discussed patient compliance, with
1226 29 32 36 37 39-41 47 49 59 63 quantifying it in some form. No trials
reported data for health economics, and only one commented
on adverse events, stating that none had occurred during
treatment sessions.36
Subgroup analysis
Only one outcome, the UPDRS motor subscore, showed
significant heterogeneity between the treatment effects of the
different classes of intervention. In all other cases, there was no
evidence of any differences (table 2). One outlying trial was the
cause of this heterogeneity in the motor score;34 when this trial
was excluded from the analysis, the result remained significant
(−3.77 points, 95% confidence interval −5.15 to −2.39;
P<0.001), but the test for between trial and between subgroup
heterogeneity was no longer significant (P=0.44 and P=0.08,
respectively).
Discussion
A variety of physiotherapy methods are used to treat people
with Parkinson’s disease. Previous reviews have focused on
one type of physiotherapy (for example, exercise, treadmill
training).19 20 This review brings together all the evidence from
the numerous trials evaluating the various physiotherapy
methods into one review to assess the overall effect of
physiotherapy versus no physiotherapy, and it also allows an
indirect comparison of the different physiotherapy methods
used.
This review provides evidence on the efficacy of physiotherapy
in the short term (mean follow-up <three months), in the
treatment of Parkinson’s disease. Significant benefit of
physiotherapy was reported for nine outcomes: gait speed, two
or six min walk test, freezing of gait questionnaire, timed up
and go test, functional reach test, Berg balance scale, and
UPDRS (total scores, activities of daily living and motor
subscores). Althoughmost of the observed differences between
the two treatment groups were small, the improvements seen
for speed, Berg balance scale, and UPDRS scores were at levels
that may be of clinical importance.64-67 By contrast, the only
patient rated quality of life outcome measure (Parkinson’s
disease questionnaire 39) showed no significant benefit from
treatment with physiotherapy, and was only reported in eight
trials.
The review also highlights the wide range of physiotherapy
techniques being used in the treatment of Parkinson’s disease.
Indirect comparisons provided no evidence of differences in the
treatment effect between different types of physiotherapy.With
all this in mind and considering the lowmethodological quality,
small size, and short duration of many of the included trials,
this evidence supporting the use of physiotherapy for people
with Parkinson’s disease must be balanced against the lack of
long term evidence currently available.
Clinical implications
We saw no evidence of an improvement in patient rated quality
of life after physiotherapy, and the observed differences in the
nine significant outcomes were relatively small. Their relevance
and benefit to patients with Parkinson’s disease must be put
into context, in terms of what is considered a recommended
minimally important difference. Little good quality evidence is
available for minimal clinically important differences in these
outcomemeasures. Data for the minimally important difference
of walking speed is lacking for people with Parkinson’s disease,
but a small cohort study of patients with stroke has been
reported. Perry and colleagues64 reported that an increase in
speed of just 0.03 m/s could translate into a change from a
limited to an unlimited household walker. The improvement in
speed of 0.04 m/s with physiotherapy reported here accords
with the findings of the Perry study.64
Data for minimally important differences for the two or six min
walk test and the freezing of gait questionnaire are also lacking.
Therefore, while a 13 m increase in distance walked would
probably be considered clinically important, the importance of
a 1.4 point improvement in the freezing of gait questionnaire is
less clear. Five points has been reported by a small test-retest
study as the minimal detectable change on the Berg balance
scale.65 In this review, we recorded a four point improvement
after physiotherapy for this outcome. The minimally important
difference for the timed up and go test in Parkinson’s disease
patients is 11 s,65 which is much larger than the 0.6 s
improvement observed within this review. Similarly, the 2 cm
improvement in the functional reach test seen in this review
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was lower than the minimally important difference of 9 cm and
7 cm for forward and backward functional reach tests,
respectively.65 The small changes observed in this review may,
for some outcomes, translate into clinically relevant
improvements in a person’s functional mobility. A greater
evidence base is required to support or refute the clinical
significance of these results.
We also observed significant improvements after physiotherapy
intervention for clinician rated UPDRS scores (that is, total
score, and activities of daily living and motor subscores). The
total score improved by six points, the activities of daily living
subscore by one point, and motor subscore by five points (table
2). The minimally important differences for the UPDRS have
been reported in two studies. One analysed data from two
independent randomised controlled trials and concluded that
the minimally important difference was eight points for the total
score, between two and three points for the activities of daily
living subscore, and five points for the motor score.66The second
study performed a cross sectional analysis on 653 patients with
Parkinson’s disease, and reported a minimally important
difference of 2.3 to 2.7 points for motor subscore and 4.1 to 4.5
points for total score.67Taking into account the recommendations
of both Schrag and colleagues66 and Shulman and colleagues,67
the improvements observed within this review are approaching
or are at these minimally important differences. This similarity
suggests that a physiotherapy intervention is beneficial in
improving clinician rated motor symptoms and may have a
positive effect on activities of daily living. However, we found
no effect on patient rated quality of life (measured using the
Parkinson’s disease questionnaire 39).
Over the past decade, steps have been taken to provide best
practice consensus in the form of Dutch guidelines for physical
therapy in patients with Parkinson’s disease (Koninklijk
Nederlands Genootschap voor Fysiotherapie).12 However, this
publication provides a guidance framework rather than a recipe
for treatment. Additionally, Parkinson’s disease is recognised
as a complex condition with an individualised presentation.68
For this reason, Morris and colleagues69 recognised the
importance of the physiotherapist understanding the specific
experience of Parkinson’s disease in each patient, and advocated
that treatment be tailored to fit a person’s complaints, lifestyle,
and personal interests, as opposed to a “one size fits all”
approach. We found no evidence of any differences in the
treatment effect between the different physiotherapy
interventions. However, data within each physiotherapy
intervention were limited, and these comparisons were based
on indirect comparisons, which should be interpreted with
caution. Therefore, physiotherapy interventions should be
compared against each other within rigorous trial designs to
determine which, if any, are effective. This analysis could
provide therapists with a menu of treatment strategies from
which they can devise individualised interventions.
Limitations of the review
The methodological quality and reporting of the majority of
trials was variable, and often inadequate. Of 39 trials, only 18
provided information on the randomisation method and only
five used a central randomisation procedure to ensure
concealment of treatment allocation. Blinded assessors were
used in 24 studies, and only nine reported using intention to
treat analysis. The lack of information in many reports may not
necessarily indicate poor implementation within the trial, but
without this information, the level of bias within each trial is
difficult to assess. The need for further improvement in the
methodological quality of trials in physiotherapy for Parkinson’s
disease was noted in another recent systematic review.70 Future
trials therefore need to ensure that their designs fulfil the
requirements of a methodologically sound, large randomised
controlled trial, and that the reporting follows the CONSORT
guidelines.71
Furthermore, the trials included in the review were relatively
small, and most compared the effect of physiotherapy
intervention with no intervention over a short period of time
(<three months). Three trials followed up their patients for three
months or longer, but all used different follow-up periods, the
longest being six months.33 37 63 With such limited data, no
meaningful meta-analysis could be performed on these longer
term data to assess the duration of any improvement after
therapy. It is also important to consider the results alongside
the possibility of a so-called honeymoon effect72 in the period
during or just after physiotherapy, which could inflate the
treatment effect in favour of physiotherapy. For a long term
disease such as Parkinson’s disease, the effect of therapy over
a much longer period is needed.
Studies included in the review all used standard physiotherapy
and Parkinson’s disease outcomes. However, Parkinson’s disease
is a multidimensional disease, and many important outcomes
were either poorly or not reported. This included data for quality
of life, the number of falls, depression and anxiety, adverse
events, and the health of the carer supporting the person with
Parkinson’s disease. We saw little focus on patient orientated
outcomes, without which studies cannot necessarily capture the
difficulties experienced by patients in everyday life or their
opinions on treatment acceptability and personal improvements.
Patient reported outcomes such as the walk 12G scale, which
has been shown to have validity in Parkinson’s disease,73 should
be more commonly used in trials of physiotherapy to increase
the effect of the studies themselves and of subsequent
meta-analyses. Furthermore, none of the reports included a
health economics analysis of the physiotherapy intervention
studied, and therefore, little is known about the cost
effectiveness and economic value of these various therapies.
Implementation of a community based professional network of
physiotherapists working according to evidence based
recommendations has been shown to reduce costs of provision
of healthcare compared with usual care.74 Unfortunately, the
evidence base, required to inform the types of techniques which
should be recommended for use in these networks, is
inconclusive.
Outcome reporting bias may have created a deceptively positive
impression of the effectiveness of the studied interventions.
Unfortunately, the proportion of outcomes that went unreported
could not be assessed here, owing to a lack of information on
trial protocol.
Implications for research
A larger and better quality body of evidence is required before
a recommendation for change in practice can be made. The
majority of the studies in this review were small and had a short
follow-up period. Larger randomised controlled trials are
needed, particularly those focusing on improving trial
methodology and reporting. Rigorousmethods of randomisation
should be used and the allocation of treatment be adequately
concealed. Data should be analysed according to intention to
treat principles, and trials should be reported according to
CONSORT guidelines.71 This review also illustrates the need
for the universal use of relevant, reliable, and sensitive outcome
measures. Additionally, only three trials looked at the benefit
of physiotherapy intervention in the longer term. To assess
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whether or how long any improvement owing to physiotherapy
intervention may last, long term follow-up should be performed
without crossover from control to active intervention.Moreover,
this review highlights the variety of physiotherapy interventions
being used in the treatment of Parkinson’s disease.More specific
trials with improved treatment strategies are needed to underpin
the most appropriate choice of physiotherapy intervention.
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What is already known this on this topic
Referral rates for physiotherapy in Parkinson’s disease are historically low in the UK
Evidence from published trials and guidelines have suggested potential benefits of physiotherapy for patients with Parkinson’s disease
What this study adds
A variety of physiotherapy methods currently exist for treating Parkinson’s disease
Physiotherapy could provide clinically meaningful benefits in the short term for patients, although many relevant trials have been of low
methodological quality, small size, and short duration. Indirect comparisons indicate little difference in treatment effect between
interventions
It is uncertain whether physiotherapy is beneficial in the longer term, and if so, which type of physiotherapy is best to deliver
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Tables
Table 1| Physiotherapy intervention classifications and trial characteristics
Examples of types of
therapy
Duration of
trial period
Duration of
treatment
Mean
duration ofMean stage
on Hoehn
Mean age
(years)
Total number
of
Number of trials
Physiotherapy
intervention
sessions
(min)
Parkinson’s
disease
(years)
and Yahr
scale
participants
(% male)
Bobath training; gait and
balance exercises; hands-on
techniques; education and
advice on transfer, posture,
physical fitness
4-12 months30-6042.465244 (69)725,26,27,28,29,30,31Physiotherapy
Strengthening and balance
training; walking; falls
prevention; neuromuscular
facilitation; resistance
exercise; aerobic training;
education; relaxing techniques
3-24 weeks30-12062.669769 (60)1432,33,34,35,36,37,38,39,40,41,42,43,44,45Exercise
Walking on treadmill with
speed or incline adjustments;
body weight supported
treadmill training; step and gait
training
4-8 weeks30-6052.468179 (61)827,31,46,47,48,49,50,51Treadmill
Three types of cueing: audio
(music, spoken instructions);
visual (computer images);
sensory (vibration)
Single session
of 13 weeks
4-3072.667371 (59)938,45,52,53,54,55,56,57,58Cueing
Tango; waltz; foxtrot12-13 weeks6072.369120 (63)259,60Dance
Tai chi; qigong12-24 weeks6062.165143 (74)460,61,62,63Martial arts
For one trial,31 60 patients split between physiotherapy and treadmill categories not included in table because group split not given. For multiple arm trials, which
are included in more than one intervention type, control arm patients (n=59) were counted twice. Web table 1 provides detailed information on individual trials.
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Table 2| Summary of results
SubgroupHeterogeneityMean difference (95% CI)
No of
participantsPhysiotherapy interventions
No of trials; no of
comparisonsOutcomes
Gait
P=0.25P=0.550.04 (0.02 to 0.06), P<0.001814General physiotherapy, exercise,
treadmill, cueing, dance, martial
arts
15;
1925,26,27,32,34,38,40,45,47,50,52,53,55,57,60
Speed (m/s)
P=0.19P=0.4413.37 (0.55 to 26.20), P=0.04242Exercise, treadmill, dance, martial
arts
6; 739,41,42,47,59,602 or 6 min walk test (m)
P=0.51P=0.190.40 (0.00 to 0.80), P=0.05169Exercise, treadmill4; 439,41,43,4910 or 20 m walk test (s)
P=0.55P=0.74−1.41 (−2.63 to −0.19),
P=0.02
298Exercise, cueing, dance4; 432,57,59,60Freezing of gait
questionnaire
P=0.97P=0.73−1.57 (−3.81 to 0.67), P=0.17350General physiotherapy, exercise,
treadmill, cueing
7; 9 27,40,45,50,53,55,57Cadence (steps/min)
P=0.23P=0.330.03 (−0.02 to 0.08), P=0.24225General physiotherapy, exercise,
treadmill, cueing, dance, martial
arts
6; 927,45,50,53,55,60Stride length (m)
P=0.47P=0.710.02 (0.00 to 0.04), P=0.06383General physiotherapy, exercise,
treadmill, cueing
5; 627,34,40,52,57Step length (m)
Functional mobility and balance
P=0.33P=0.12−0.63 (−1.05 to −0.21),
P=0.003
639Exercise, cueing, dance, martial
arts
9; 1034,36,37,40,42,43,52,57,60Timed up and go test
(s)
P=0.48P=0.152.16 (0.89 to 3.43), P<0.001393Exercise, cueing4; 433,41,43,57Functional reach test
(cm)
P=0.47P=0.063.71 (2.30 to 5.11), P<0.001385Exercise, treadmill, dance, martial
arts
5; 633,36,44,46,60Berg balance scale
P=0.32P=0.612.40 (−2.78 to 7.57), P=0.3666Exercise, cueing3; 337,42,58Activity specific balance
confidence
Falls
P=0.28P=0.44−1.91 (−4.76 to 0.94), P=0.19353Exercise, cueing4;432,36,46,57Falls efficacy scale
Clinician rated disability (UPDRS)
P=0.01P=0.03−6.15 (−8.57 to −3.73),
P<0.001
207General physiotherapy, exercise,
treadmill
3; 426,27,34Total
Subscores
P=0.82P=0.80−0.44 (−0.98 to 0.09), P=0.10105General physiotherapy, treadmill2; 326,27Mental
P=0.19P=0.28−1.36 (−2.41 to −0.30),
P=0.01
157General physiotherapy, treadmill,
dance
3; 426,27,59Activities of daily living
P<0.001P<0.001−5.01 (−6.30 to −3.72),
P<0.001
593General physiotherapy, exercise,
treadmill, cueing, dance, martial
arts
12; 1425,26,27,34,40,47,52,53,58,59,60,63Motor
Patient rated quality of life (Parkinson’s disease questionnaire 39)
P=0.87P=0.89−0.38 (−2.58 to 1.81), P=0.73405General physiotherapy, exercise,
treadmill, cueing, dance, martial
arts
7; 825,32,37,39,47,57,60Summary index
P=0.11P=0.11−1.43 (−8.03 to 5.18), P=0.67105General physiotherapy, dance,
martial arts
2; 329,60Mobility subscore
All results (except for the 10 or 20 m walk test) favoured physiotherapy intervention.
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Figures
Fig 1 Trial flow diagram to summarise the stages of systematic review
Fig 2 Review authors’ judgments about each risk of bias item, presented as percentage across all included studies
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Fig 3 Comparison of physiotherapy interventions in relation to speed (m/s). Studies denoted as a or b distinguishes those
published by the same first author and in the same year
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Fig 4 Comparison of physiotherapy interventions with controls in relation to the timed up and go test (s). Studies denoted
as a or b distinguishes those published by the same first author and in the same year
Fig 5 Comparison of physiotherapy interventions with controls in relation to the functional teach test (cm)
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Fig 6 Comparison of physiotherapy interventions with controls in relation to the Berg balance scale. Studies denoted as a
or b distinguishes those published by the same first author and in the same year
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Fig 7 Comparison of physiotherapy interventions with controls in relation to the UPDRS motor subscale. Studies denoted
as a or b distinguishes those published by the same first author and in the same year
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